Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Tromlieva 25mg Tablet 7'S
Manufacturer/Marketed By : Allieva Pharma Pvt. Ltd.
$29.95 $9.49
Tromlieva 25mg Tablet 7'S is an anticoagulant drug belonging to the thrombopoietin (TPO) receptor agonist category, containing the active ingredient Eltrombopag. It is used to treat low platelet counts caused...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
ELTROMBOPAG
Active Pharmaceutical Ingredient
Tromlieva 25mg Tablet 7'S
29,95$
9,49$
Tromlieva 25mg Tablet 7'S is an anticoagulant drug belonging to the thrombopoietin (TPO) receptor agonist category, containing the active ingredient Eltrombopag. It is used to treat low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C (HCV) infection. ITP is an autoimmune disorder where the immune system destroys platelets, which are blood cells essential for clotting and protecting blood vessel walls. Low platelet levels can lead to severe bleeding and bruising. This tablet is also indicated for treating adults with severe aplastic anemia, a serious condition where the bone marrow fails to produce sufficient new blood cells. This drug should not be used in individuals with known hypersensitivity or allergic reactions to the medication or its components. Allergic reactions can range from mild to severe and include symptoms like rash, itching, swelling, dizziness, or difficulty breathing. Tromlieva 25mg Tablet 7'S is contraindicated in patients with severe liver impairment or active liver disease, as it may cause hepatotoxicity (liver damage), indicated by increased liver enzymes and bilirubin levels. Patients should be monitored closely to avoid further liver function deterioration. Your doctor may also check for cataracts or bleeding in or around the retina (the light-sensitive layer at the back of the eye).
Active Pharmaceutical Ingredient
Uses
• Low platelet counts caused by primary immune thrombocytopenia (ITP) or hepatitis C virus (HCV) infection.
• Severe aplastic anemia.
Benefits
Tromlieva 25mg Tablet 7'S stimulates megakaryocytes (large bone marrow cells responsible for producing platelets). By increasing the platelet count, this drug helps prevent bleeding and bruising.
Side Effects
Common side effects include:
Most Common Side Effects
Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.
Common Side Effects
• Nausea
• Diarrhea, abdominal pain
• Common cold
• Cough
• Respiratory tract infection
• Back pain
• Fever
• Loss of appetite
• Hair loss
• Swelling in feet or hands
• Headache, dizziness
• Mouth and throat pain
• Joint pain
How To Use
This is an orally available prescription drug. Your doctor will determine the dose and duration of the drug based on your condition. Always take Tromlieva 25mg Tablet 7'S as prescribed. It can be taken with or without food, but do not chew, crush, or break the tablet. Swallow it whole with water.
Safety Advice
• Breast Feeding: It is unclear whether this drug passes into breast milk. If you are breastfeeding or planning to, consult your doctor.
• Alcohol: The interaction between Tromlieva 25mg Tablet 7'S and alcohol is not well established. Discuss alcohol consumption with your doctor.
• Liver: Patients with severe liver conditions should use this medication cautiously. Dose adjustments may be necessary. Inform your doctor about any liver issues before starting treatment.
• Lungs: The effect of this medication on patients with lung problems is unknown. Consult your doctor if you have any lung conditions.
• Driving: Avoid driving or operating heavy machinery after taking Tromlieva 25mg Tablet 7'S, as it may cause dizziness and impair concentration.
• Pregnancy: Tromlieva 25mg Tablet 7'S is not recommended during pregnancy as it may harm the fetus. Inform your doctor if you are pregnant, suspect you may be, or plan to become pregnant during treatment.
Disclaimer
Sidmex Inovia s'efforce de fournir des informations exactes et fiables. Cependant, l'ensemble du contenu de ce site web, y compris les descriptions et compositions des produits, est fourni à titre informatif uniquement et ne saurait se substituer à un avis, un diagnostic ou un traitement médical professionnel.
Il est conseillé aux utilisateurs de consulter un professionnel de santé qualifié avant toute décision médicale. Les informations fournies ne doivent pas être utilisées pour l'autodiagnostic ou l'automédication.
Tous les produits présentés sont exclusivement destinés aux professionnels (B2B) et aux demandes de renseignements en gros. Sidmex Inovia ne promeut pas la consommation directe par les particuliers et vise à soutenir, et non à remplacer, la relation entre le professionnel de santé et le patient.
Les noms de produits, marques et logos appartiennent à leurs propriétaires respectifs et leur utilisation n'implique aucune affiliation ni aucun parrainage. Sidmex Inovia décline toute responsabilité quant aux conséquences découlant de l'utilisation des informations fournies sur ce site web.